Status:
WITHDRAWN
Comparison of Adding EMEND to PONV/PDNV Treatment Regimen
Lead Sponsor:
University of Nebraska
Conditions:
Postoperative Nausea and Vomiting
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study is looking at whether the addition of Aprepitant (Emend), an antiemetic, will provide added efficacy if added to 2 drugs that are already used as a standard of care for post-operative nause...
Detailed Description
This study is looking at whether the addition of a fairly new drug for the treatment of post-operative nausea and vomiting (PONV) and post-discharge nausea and vomiting (PDNV) will provide added effic...
Eligibility Criteria
Inclusion
- patients with at least 2 of the common risk factors for PONV/PDNV; patients having a procedure deemed at high risk for PONV/PDNV
Exclusion
- patients under 19 years of age; pregnant and breast-feeding patients
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01186029
Start Date
September 1 2011
End Date
September 1 2011
Last Update
August 30 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.